Updated annually, the British Pharmacopoeia (BP) is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products.

It includes approximately 4,000 monographs which are legally enforced by the Human Medicines Regulations 2012. Medicinal products or active pharmaceutical ingredients sold or supplied in the UK must comply with the relevant monograph.

All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.

New for the BP 2024
The BP 2024 supersedes the BP 2023 and becomes legally effective on 1 January 2024. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.

• 27 new BP monographs, 17 new Ph. Eur. monographs.
• 93 amended BP monographs.
• All monographs from the Ph. Eur. 11th edition
• Ph. Eur. supplements 11.4 to 11.6 included as in-year online and download product updates
• We are updating the BP website to improve your experience of using the site.
  Updated features for the 2024 edition include:
  • A fresh and user-friendly site design, coupled with improved navigation
  • Enhanced purchasing journeys for a seamless experience
  • Enhanced layout allows you to search and find the monographs you need
  • Advanced in-publication search functionality
  • A revamped timeline and tracked changes feature, enabling you to track the evolution of monographs over time

The BP 2024 Single User Online Subscription Edition plus Archive includes:

• A single-user online licence* for BP Online valid from 1st August 2023 until 31 March 2025
• Access to the BP Archive, including all editions sine BP 2014, until 31 March 2025

Other formats are available to ensure users get the best value access to the information they need.

*NOTE: Single-user licences are granted solely to one designated holder. Multi-user licences are available.